ALPS GROUP INC (ALPS) Stock Price & Overview
NASDAQ:ALPS • KYG0231P1081
The current stock price of ALPS is 0.97 USD. Today ALPS is down by -3.96%. In the past month the price increased by 3.67%.
ALPS Key Statistics
- Market Cap
- 167.267M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.17
- Dividend Yield
- N/A
ALPS Stock Performance
ALPS Stock Chart
ALPS Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to ALPS.
ALPS Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ALPS. ALPS has a bad profitability rating. Also its financial health evaluation is rather negative.
ALPS Earnings
ALPS Forecast & Estimates
ALPS Groups
Sector & Classification
ALPS Financial Highlights
Over the last trailing twelve months ALPS reported a non-GAAP Earnings per Share(EPS) of -0.17. The EPS decreased by -216.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -25.77% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALPS Ownership
ALPS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.34 | 401.392B | ||
| AMGN | AMGEN INC | 16.55 | 202.383B | ||
| GILD | GILEAD SCIENCES INC | 16.52 | 184.425B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 25.4 | 126.804B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.57 | 81.619B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.95 | 42.754B | ||
| INSM | INSMED INC | N/A | 31.007B | ||
| NTRA | NATERA INC | N/A | 28.197B | ||
| BIIB | BIOGEN INC | 11.85 | 27.651B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.24 | 23.485B | ||
| MRNA | MODERNA INC | N/A | 21.714B | ||
| EXAS | EXACT SCIENCES CORP | 340.18 | 19.732B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.591B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ALPS
Company Profile
Alps Group, Inc. operates as a biotechnology company that integrates research and development, medical services, and wellness solutions. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2025-10-31. The firm has cultivated a diverse pipeline covering various biotechnology research areas. This includes initiatives focused on MyImmune (NK cells), CAR-T cells, COVID-19 mRNA vaccine, diabetes therapeutics, and advancements in stem cell technologies such as induced Pluripotent Stem Cells (iPSCs) and messenger ribonucleic acid (mRNA) platform technology. The firm provides aesthetic treatments, cosmetic procedures, general healthcare and wellness services. The Company’s aesthetic services and cosmetic surgery services include non-surgical aesthetic services and surgical aesthetic services. The company operates a molecular laboratory and a cGMP cell and gene therapy research and cultivation laboratory.
Company Info
IPO: 2025-10-31
ALPS GROUP INC
Unit E-18-01 & E-18-02, Level 18,, Icon Tower (East), No.1,Jalan 1/68F,
KUALA LUMPUR WILAYAH PERSEKUTUAN MY
Employees: 0
Phone: 60321631113
ALPS GROUP INC / ALPS FAQ
What does ALPS do?
Alps Group, Inc. operates as a biotechnology company that integrates research and development, medical services, and wellness solutions. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2025-10-31. The firm has cultivated a diverse pipeline covering various biotechnology research areas. This includes initiatives focused on MyImmune (NK cells), CAR-T cells, COVID-19 mRNA vaccine, diabetes therapeutics, and advancements in stem cell technologies such as induced Pluripotent Stem Cells (iPSCs) and messenger ribonucleic acid (mRNA) platform technology. The firm provides aesthetic treatments, cosmetic procedures, general healthcare and wellness services. The Company’s aesthetic services and cosmetic surgery services include non-surgical aesthetic services and surgical aesthetic services. The company operates a molecular laboratory and a cGMP cell and gene therapy research and cultivation laboratory.
What is the stock price of ALPS GROUP INC today?
The current stock price of ALPS is 0.97 USD. The price decreased by -3.96% in the last trading session.
Does ALPS GROUP INC pay dividends?
ALPS does not pay a dividend.
What is the ChartMill technical and fundamental rating of ALPS stock?
ALPS has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the PE ratio for ALPS stock?
ALPS GROUP INC (ALPS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.17).
What is ALPS GROUP INC worth?
ALPS GROUP INC (ALPS) has a market capitalization of 167.27M USD. This makes ALPS a Micro Cap stock.